Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Research aims to develop vaccine against future COVID viruses
United Press International via Yahoo News· 20 hours agoScientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that...
New omicron 'FLiRT' variants account for most COVID-19 cases in the US
Scripps News via AOL· 11 hours agoThe IDSA says that current data shows that JN.1 is highly effective at evading the immune system,...
Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds
Center for Infectious Disease Research and Policy· 4 days agoToday, researchers from the University of Minnesota published evidence that the common diabetes drug...
COVID-19: What to know about the new variants; what are the symptoms of FLiRT?
FOX 25 Boston· 21 hours agoA new group of COVID-19 variants are sparking concerns about a potential flare-up of the virus over...
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Medical Xpress· 7 days agoThere is no risk for new-onset seizure incidence for individuals receiving a severe acute...
COVID-19 variants called FLiRT are spreading across US
FOX 29 Philadelphia· 16 hours agoA new group of COVID-19 variants is circulating across the United States. According to tracking by...
ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testing
GenomeWeb News· 7 days agoSaliva is a promising sample type for molecular diagnostic testing in infectious diseases beyond ...
High-risk Albertans urged to get another vaccine dose as COVID-19 cases ticking up
CBC via Yahoo News· 17 minutes agoAfter trending downward for several months, COVID-19 is on the upswing in Alberta once again.The...
Scientists tried to give people COVID — and failed
Nature· 6 days agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...